baber/WOPTO huggingface dataset:
Patent AU-2020325639-A1 (AU)
Title: Multi-metal layer WVTR barrier products on water vapour and oxygen permeable bio-based substrates
Inventor: RASETTO VALERIA
IPC: C23C14/20
Filed: 2020-07-31
Abstract: The invention relates to a metallized multilayer sheet material for packaging having a water vapour transmission rate (WVTR) of below 5 g/m²/day at 38°C RH:90% comprising: - a water vapour permeable sheet substrate (2; 22; 32; 42, 52), and - at least two metallized layers (4, 6; 24, 27; 34, 37; 44, 46; 54, 56), each covered directly by a solvent based polymeric coating layer (5, 7; 25, 28; 35, 38; 45, 47; 55, 57), wherein the cumulated metallized layers have an optical density (OD) of at least 2.5 and/or a thickness of at least 15 nm.
Patent AU-2020345972-A1 (AU)
Title: Universal donor selection method to identify NK-cell-donors
Inventor: LEE DEAN
IPC: A61K35/12
Filed: 2020-09-14
Abstract: Described herein are compositions comprising universal donor natural killer (NK) cells, populations of such cells, methods of obtaining and preparing such cells, and methods of use of such cells and compositions in medical treatment of cancers and infectious disease. In one aspect, the present disclosure relates to a method of selecting universal donor NK cells for therapeutic administration to a subject in need thereof.
Patent AU-2020349474-A1 (AU)
Title: Optimizing utilization and marketing of car washes
Inventor: GUNDAPPA SANGAMESH
IPC: H04L65/40
Filed: 2020-09-16
Abstract: A first data packet can be received from an origination terminal at a remote server operatively coupled to the origination terminal and an end user terminal. The first data packet can have a plurality of offers and image or video data acquired by an image/video sensor. The image or video data can be processed by the remote server using an image processing algorithm to estimate a current idle time associated with the origination terminal. One or more aspects of the plurality of offers can be controlled by the remote server based on the current idle time. A second data packet including the plurality of offers can be transmitted to the end user terminal by the remote server. A selection of a preferred offer of the plurality of offers can be received from the end user terminal at the remote server. The preferred offer can be provided to the origination terminal.
Patent AU-2020353390-A1 (AU)
Title: Neoglycoconjugates as vaccines and therapeutic tools
Inventor: SHIAO TZE CHIEH
IPC: A61K38/16
Filed: 2020-09-18
Abstract: Neoglycoconjugates as immunogens and therapeutic/diagnostic tools are described herein. The neoglycoconjugates are produced by conjugating a carbohydrate antigen intermediate to a free amine group of a carrier material (e.g., carrier protein). The intermediate comprises a linker having a first end and a second end, the first end being conjugated to a carbohydrate antigen via a thio ether bond and the second end comprising a functional group reactable with a free amine group. Following coupling, the carbohydrate antigen becomes covalently bound to the carrier material via an amide, a carbamate, a sulfonamide, a urea, or a thiourea bond, thereby producing the neoglycoconjugate. Applications of the neoglycoconjugates as antigens, immunogens, vaccines, and in diagnostics are also described. Specifically, the use of (neo)glycoconjugates as vaccine candidates and other therapeutic tools against cancers, viruses such as SARS-CoV-2, and other diseases characterized by expression of aberrant glycosylation are also described.
Patent AU-2020400104-A1 (AU)
Title: System and method for controlling a shock output of an electronic animal trap
Inventor: KAUFFMAN MATTHEW
IPC: A01M31/00
Filed: 2020-12-11
Abstract: A system for controlling a shock output of an electronic animal trap includes a battery (20), a transformer (50) having a primary coil (52) connected to the battery (20), and a controller (10) connected to the battery (20) and the primary coil (52). The controller (10) has a shock cycle module (16) determining a battery capacity (24) of the battery (20) and determining a shock enable time (230) based on the battery capacity (24). The shock cycle module (16) controls a primary current (I
Patent AU-2020403497-A1 (AU)
Title: Free-cutting copper alloy and method for manufacturing free-cutting copper alloy
Inventor: OISHI KEIICHIRO
IPC: C22C9/04
Filed: 2020-11-30
Abstract: A free-cutting copper alloy comprising more than 59.7% but less than 64.7% of Cu, more than 0.60% but less than 1.30% of Si, more than 0.001% but less than 0.20% of Pb, more than 0.001% but less than 0.10% of Bi, and more than 0.001% but less than 0.15% of P, the remaining portion being Zn and unavoidable impurities, wherein the total amount of Fe, Mn, Co, and Cr is less than 0.45%, the total amount of Sn and Al is less than 0.45%, 56.7≤Cu-4.7×Si+0.5×Pb+0.5×Bi-0.5×P≤59.7 and 0.003≤Pb+Bi<0.25 are satisfied, 0.02≤Bi/(Pb+Bi)≤0.98 is satisfied if 0.003≤Pb+Bi<0.08 is satisfied, 0.01≤Bi/(Pb+Bi)≤0.40 or 0.85≤Bi/(Pb+Bi)≤0.98 is satisfied if 0.08≤Pb+Bi<0.13 is satisfied, 0.01≤f3=Bi/(Pb+Bi)≤0.33 is satisfied if 0.13≤Pb+Bi<0.25 is satisfied, the metal structure of the alloy comprises an α phase and a β phase, and 17≤β≤75, 7.0≤(Bi+Pb-0.001)
Patent AU-2020419182-A1 (AU)
Title: Compositions containing exosome carrying NF-KB inhibitors and methods of using thereof
Inventor: CHOI CHULHEE
IPC: A61P29/00
Filed: 2020-12-30
Abstract: The present invention is related to compositions containing extracellular vesicles (exosomes) and methods of using the same for increasing lifespan of fetus, viability of fetus, or viability of newborn, for treating inflammation in uterus and/or fetus, for delaying preterm birth, or for treating a condition related to inflammation in uterus and/or fetus, wherein the extracellular vesicles comprising a nuclear factor kappa beta (NF-κB) inhibitor and a photo-specific binding protein.
Patent AU-2021200743-A1 (AU)
Title: Plastic film bottom bag and use thereof as well as blank for a plastic film bottom bag
Inventor: DONNER GEORG
IPC: B65D75/04
Filed: 2021-02-05
Abstract: The present invention relates to a plastic film bottom bag, in which, in the transition from 
the plastic film front wall to the side wall sections of the adjoining plastic film side walls, the 
plastic film front wall and the side wall sections are welded, in particular welded to one an
other, and/or, in which, in the transition from the plastic film rear wall to the side wall sec
tions of the adjoining plastic film side walls, the plastic film rear wall and the side wall sec
tions are welded, in particular welded to one another, in particular so as to form a seam or 
casing seam. The present invention further relates to a plastic film bottom bag, in which at 
least one, in particular both, plastic film side walls are provided with an, in particular out
wardly facing, side crease welded or adhesive joint extending from or at a distance from 
the bag opening edge in the direction of the bag end or up to the bag end. The invention 
further relates to blanks for the plastic film bottom bags according to the invention and to 
the use of the plastic film bottom bags according to the invention as, in particular repeated
ly, reusable bags or reusable handbags.  
37
1 
30 3072 66 8 
70 40 
2842 
228 
6 6 _ 16 
22 17 
24 4 
2518 
26 20 
12 3 
38 10 
31264 52 56 54 58 7662 
60 80 
68 
Figure 1 
1/13
Patent AU-2021203470-A1 (AU)
Title: Screen device
Inventor: OKACHI YASUBUMI
IPC: E06B9/54
Filed: 2021-03-19
Abstract: of the disclosure 
In a screen device (SD), a screen retaining member (9) formed by detachably attaching 
a plurality of needle-like parts (92) in intervals to a longitudinal base part (91) which is 
5 bendable in a pivotally moving direction of each of the first guide units (63), and in an 
attached condition of the screen retaining member (9), the base part (91) is supported 
between the rail part (63g) and the supporting piece (63h) of each of the first guide units (63) 
and all of the needle-like parts (92) protrude inwardly between opposing side walls (63a, 
63a) of each of the first guide unis (63).  
10 
17726142_1 (GHMatters) P116260.AU
Patent AU-2021204115-A1 (AU)
Title: Long-acting FGF21 fusion proteins and pharmaceutical composition comprising same
Inventor: KIM JUN HWAN
IPC: A61K38/18
Filed: 2021-06-18
Abstract: The present invention provides a fusion protein comprising an FGF21 mutant 
5 protein and an Fc region of an immunoglobulin. The fusion protein according to the 
present invention exhibits improved pharmacological efficacy, in vivo duration and 
protein stability, and a pharmaceutical composition comprising the fusion protein as an 
active ingredient may be effectively used as a therapeutic agent for diabetes, obesity, 
dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease or non-alcoholic 
10 steatohepatitis.
Patent AU-2021209195-A1 (AU)
Title: Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
Inventor: RAMSBORG CHRIS
IPC: C12N5/0781
Filed: 2021-07-27
Abstract: The present disclosure relates in some aspects to methods, cells, and compositions for 
preparing cells and compositions for genetic engineering and cell therapy. Provided in some 
embodiments are streamlined cell preparation methods, e.g., for isolation, processing, incubation, 
and genetic engineering of cells and populations of cells. Also provided are cells and compositions 
produced by the methods and methods of their use. The cells can include immune cells, such as 
T cells, and generally include a plurality of isolated T cell populations or types. In some aspects, 
the methods are capable of preparing of a plurality of different cell populations for adoptive therapy 
using fewer steps and/or resources and/or reduced handling compared with other methods.
Patent AU-2021221554-A1 (AU)
Title: Packaging compliance method
Inventor: ADLER NIGEL
IPC: G06T7/00
Filed: 2021-08-24
Abstract: A packaging compliance method comprising: 
associating a packaging label having a unique first digitally readable element 
with a unique record in a database; the unique record in the database containing 
information about an item of produce; 
applying the packaging label directly to the item of produce or packaging 
containing the item of produce; 
packing two or more items of produce into a container having a container label; 
the container label having a container digitally readable element to determine the 
required items of produce that should be located within the container; 
reading all of the unique first digitally readable elements located within the 
container to obtain the information from the unique records associated with the unique 
first digitally readable elements; 
reading the container digitally readable element to obtain information on the 
required items of produce that should be located within the container; 
comparing the information from the unique records associated with the read 
unique first digitally readable elements and information of the required items of 
produce that should be located within the container to determine if the container 
contains the required items of produce; 
rejecting the container if the container does not contain the required items of 
produce to complete packaging compliance.  
15
1/1 
n4
In4O 
Q)I'o 
In4 
4-
Patent AU-2021229533-A1 (AU)
Title: 3D concrete printing with flexible reinforcing structure
Inventor: GOUWY MATTHIAS
IPC: B32B13/14
Filed: 2021-02-16
Abstract: A concrete construction is made by 3D concrete printing and comprises: - two or more layers (100, 102) of cementitious material extruded one above the other, and - a reinforcing structure (104) reinforcing the two or more layers (100, 102). The reinforcing structure (104) has a length and a height. The reinforcing structure (104) comprises at least two flexible longitudinal elongated steel elements (208, 210, 308, 310) running in lengthwise direction. The reinforcing structure (104) further comprises one or more flexible transverse steel elements (214, 314) forming an angle with the lengthwise direction so that these flexible transverse steel elements (214, 314) are present in the two or more layers (100, 102). The structure (104) further comprises a positioning element for positioning the at least two flexible longitudinal elongated elements (208, 210, 308, 310) and the flexible transverse steel elements (214, 314), a polymer coating or yarns making stitches. The polymer coating or the stitches are applied on the at least two flexible longitudinal elongated steel elements (208, 210, 308, 310), on the flexible transverse steel elements (214, 314) and on the positioning element thereby making a bond between the at least two flexible longitudinal elongated steel elements (208, 210, 308, 310), the flexible transverse steel elements (214, 314) and the positioning element. A concrete construction made by 3D concrete printing comprises: - two or more layers (100, 102) of cementitious material extruded one above the other, and - a reinforcing tape (104) reinforcing at least two of the layers (100, 102). The reinforcing tape (104) comprises at least one steel cord (106). The presence of a steel cord (106) gives more flexibility to the reinforcement.
Patent AU-2021231205-A1 (AU)
Title: Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
Inventor: FUCHS NORBERT
IPC: A61P31/12
Filed: 2021-03-03
Abstract: The present invention provides a pharmaceutical composition containing a selenite-containing compound and a pharmaceutically acceptable acid, selected from citric acid, acetic acid, malic acid, carbonic acid, sulfuric acid, nitric acid, hydrochloric acid, fruit acids and mixtures thereof, for use in reducing progression of cervical cell abnormalities in a female patient, wherein the patient is p16-positive and Ki-67-positive at least in a region of the cervix uteri. The composition is applied intravaginally.
Patent AU-2021237718-A1 (AU)
Title: Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
Inventor: BYUN DANIEL H
IPC: C07H19/16
Filed: 2021-03-19
Abstract: The present disclosure provides prodrugs of 4'-C-substituted-2- halo-2'-deoxyadenoside nucleosides, and compositions, methods and kits thereof. Such compounds can be useful for treating viral infections including, human immunodeficiency virus. The compounds have the following formula (I).
Patent AU-2021240254-A1 (AU)
Title: Vacuum adiabatic body and refrigerator
Inventor: JUNG WONYEONG
IPC: F25D23/06
Filed: 2021-09-30
Abstract: A vacuum adiabatic body comprising: a first plate; a second plate; a seal that seals the first plate 
and the second plate to provide an inner space in a vacuum state; and a peripheral adiabatic 
material provided outside the inner space, wherein the vacuum adiabatic body further includes a 
main portion and a side portion.  
18086220_1 (GHMatters) P43827AU02
Patent AU-2021240344-A1 (AU)
Title: 5-amino-8-(4-pyridyl)-(1,2,4)triazolo(4,3-c)pyrimidin-3-one compounds for use against cancer
Inventor: BROWN GILES ALBERT
IPC: A61P35/00
Filed: 2021-03-25
Abstract: Described herein are triazalone compounds of Formula (I) and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds of Formula (I) and pharmaceutically acceptable salts thereof can be useful as adenosine receptor antagonists, for example in the treatment of diseases or conditions mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders.
Patent AU-2021246385-A1 (AU)
Title: Bispecific antibody
Inventor: SHIKU HIROSHI
IPC: A61K39/395
Filed: 2021-03-29
Abstract: Provided are a novel antibody usable as an antitumor agent and an antitumor agent that comprises a molecule containing the antibody, etc. as an active ingredient.　An antibody that contains heavy chain CDRH1 comprising the amino acid sequence represented by SEQ ID NO: 54, heavy chain CDRH2 comprising the amino acid sequence represented by SEQ ID NO: 55, heavy chain CDRH3 comprising the amino acid sequence represented by SEQ ID NO: 56, light chain CDRL1 comprising the amino acid sequence represented by SEQ ID NO: 57 or light chain CDRL1 comprising an amino acid sequence that is identical with the amino acid sequence represented by SEQ ID NO: 57 except that the seventh amino acid is W and/or the eighth amino acid is K, light chain CDRL2 comprising the amino acid sequence represented by SEQ ID NO: 58, and light chain CDRL3 comprising the amino acid sequence represented by SEQ ID NO: 59 or light chain CDRL3 comprising an amino acid sequence that is identical with the amino acid sequence represented by SEQ ID NO: 57 except that the second amino acid is A or S; or a binding fragment of the antibody.
Patent AU-2021259879-A1 (AU)
Title: Fluorescent polynucleotide sequencing methods and compositions
Inventor: HUBER MARTIN
IPC: C12N9/14
Filed: 2021-04-26
Abstract: The invention comprises a method for determining a nucleotide sequence of a polynucleotide. In some embodiments, the method comprises providing a solid state substrate comprising a cis side and a trans side. The fluorescently labeled polynucleotide strand comprises (i) a proximal end that is attached to the carrier particle, (ii) a distal end that is cleavable by an exonuclease, and (iii) at least one fluorescently labeled nucleotide comprising a fluorescent label. The trans side of the substrate is illuminated with excitation light to create a fluorescence excitation zone. While the substrate is illuminated, the fluorescently labeled polynucleotide strand is reacted with an exonuclease so that mononucleotides are released serially from the distal end of the strand and diffuse through the fluorescence excitation zone, so that fluorescently labeled mononucleotides in the excitation zone emit fluorescent signals. The fluorescent signals are detected as a function of time, enabling the deduction of a polynucleotide sequence.
Patent AU-2021269283-A1 (AU)
Title: Accommodating intraocular lenses and methods of manufacturing
Inventor: HILDEBRAND DANIEL
IPC: G02B1/06
Filed: 2021-11-15
Abstract: An intraocular lens, comprises an optic body, a projection extending radially outwards from a 
peripheral surface of the optic body, wherein the projection comprises a haptic contact 
surface, wherein the haptic contact surface comprises a flat surface; and a haptic having a free 
distal end and a proximal portion secured to the projection along the flat surface of the haptic 
contact surface without the haptic extending into the projection.
Patent AU-2021284362-A1 (AU)
Title: Dextran-alpha-glucan graft copolymers and derivatives thereof
Inventor: ADELMAN DOUGLAS J
IPC: C08L5/02
Filed: 2021-06-03
Abstract: Disclosed herein are compositions comprising at least one alpha-glucan graft copolymer derivative compound (e.g., ether or ester) having a degree of substitution (DoS) up to about 3.0. The precursors of these derivative compounds are graft copolymers that comprise a dextran backbone and alpha-glucan side chains. At least about 30% of the glycosidic linkages of the alpha-glucan side chains are alpha-1,3 glycosidic linkages. Further disclosed are methods of producing graft copolymer derivatives, as well as their use in various applications and products.
Patent AU-2021288923-A1 (AU)
Title: Small-molecule inhibitors of the FRS2-FGFR interaction and their use in medicine, in the prevention and treatment of cancer
Inventor: SCHNEIDER GISBERT
IPC: A61K31/435
Filed: 2021-06-08
Abstract: The present invention relates to small-molecule inhibitors of the FRS2-FGFR interaction. The present invention relates the small-molecule inhibitors for use as a medicament and for use in cancer or metastasis treatment or prevention.
Patent AU-2021306626-A1 (AU)
Title: Manufacturing method for an absorbent article comprising a pocket and absorbent article being producible thereby
Inventor: HELLMOLD JENS
IPC: A61F13/51
Filed: 2021-07-07
Abstract: A manufacturing method is provided. According to a first step (100), the method comprises providing a backsheet layer, a cover strip layer, and an absorbent core layer in order to manufacture an absorbent article comprising a pocket being accessible from the non-absorbent side of the absorbent article. Then, according to a second step (101), the method comprises cutting an opening into the backsheet layer. In this context, the cutting is speed-synchronized with respect to the provision of the backsheet layer in such a manner that the opening is placed at the same position for every absorbent article. Furthermore, according to a third step (102), the method comprises placing the cover strip layer between the backsheet layer and the absorbent core layer.
Patent AU-2021321459-A1 (AU)
Title: Integrated solar hydrogen production module
Inventor: JACOBS LOURENS
IPC: H02S40/38
Filed: 2021-08-06
Abstract: An integrated solar hydrogen production module (10) comprise a plurality of PV cells (14) supported on a housing of the module (10). The module (10) has an energy storage system (16) which includes a rechargeable metal ion battery and a flow battery (60). The metal ion battery is charged by the PV cells (14). An electrolyser (18) for converting water to gaseous hydrogen and oxygen can be powered directly by the PV cells or by either of the rechargeable metal ion battery and a flow battery (60). The PV cells (14), the metal-ion battery, the flow battery membrane (60) and the electrolyser (18) are electrically coupled together and integrated into or carried by the module housing. Electrically powered and solar thermal heaters (36, 38) can be incorporated into or with the module to heat the water in the electrolysers. A pump (34) pressurises the water to facilitate the pressurisation of hydrogen and oxygen produced by the electrolysis.
Patent AU-2021322320-A1 (AU)
Title: Therapies for treating AML and uses of RARA agonists, hypomethylating agents, and BCL-2 inhibitors
Inventor: KANG-FORTNER QING
IPC: A61P35/02
Filed: 2021-08-06
Abstract: The present disclosure features, inter alia, methods of treating a patient who has been diagnosed with acute myelomonocytic leukemia (the M4 subtype of AML), acute monocytic leukemia (the M5 subtype of AML), or myelodysplastic syndrome (MDS). The methods include administering to the patient a therapeutically effective amount of a retinoic acid receptor-alpha (RARA) agonist or a pharmaceutically acceptable salt thereof. In one or more embodiments (e.g., in treating MDS), administering the RARA agonist or the pharmaceutically acceptable salt thereof commences prior to determining whether the patient expresses a RARA biomarker and/or without consideration of the status of the RARA biomarker.
Patent AU-2021380856-A1 (AU)
Title: Electrical outlet cutting jig
Inventor: MADDUMA PATABANDIGE CHAMINDA
IPC: B25H7/02
Filed: 2021-05-28
Abstract: ELECTRICAL OUTLET CUTTING JIG 
Disclosed herein is an electrical outlet cutting jig that includes a ruler and a body 
having a lower perimeter, wherein the body includes a first channel defined along a first axis 
of the body. The body also includes a first level indicator and a second level indicator 
orthogonal to the first level indicator to enable a user to align the cutting jig correctly. The 
first channel is configured to receive the ruler such that a lower surface of the ruler is flush 
with the lower perimeter of the body and such that the ruler can slide within the first channel.  
The ruler enables the user to position the body of the cutting jig at a predetermined distance 
from a location, such as a door frame, floor, skirting board, or the like.
- 26/33
A-~.  
I 
A2x 
.~I 0 
r r t. ~ 
~ '.' 
H~ II li-i .U
/ 
/ 
H / 
'V I 
~ -, 
~- ~ if 
'4 
\~ 
~ V 
\ 
/ 
N 
N,